Insider Transactions last 24 months for Cidara Therapeutics, Inc. - NSDQ: CDTX
| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Davarpanah Nicole Negar | Chief Medical Officer | 09/11/2025 | DS | Direct | COM | 474 | $62.86 | $29,796.92 | 31,418 |
| Ra Capital Management, L.P. | Director | 06/26/2025 | AP | Indirect | COM | 2,272,727 | $44.00 | $99,999,988.00 | 3,365,523 |
| Mineo Chrysa | Director | 06/03/2025 | AP | Direct | COM | 1,050 | $23.44 | $24,614.10 | 3,320 |
| Mineo Chrysa | Director | 06/02/2025 | AP | Direct | COM | 2,270 | $21.71 | $49,281.47 | 2,270 |
| Davarpanah Nicole Negar | Chief Medical Officer | 05/01/2025 | AA | Direct | COM | 10,000 | $0.00 | $0.00 | 31,692 |
| Ward Shane | COO & CLO | 03/31/2025 | AA | Direct | COM | 25,000 | $0.00 | $0.00 | 39,674 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/11/2025 | DS | Direct | COM | 1,773 | $21.96 | $38,939.69 | 16,215 |
| Ward Shane | COO & CLO | 03/11/2025 | DS | Direct | COM | 1,664 | $21.96 | $36,542.11 | 14,674 |
| Karbe Frank | Chief Financial Officer | 02/24/2025 | AA | Direct | COM | 57,500 | $0.00 | $0.00 | 57,500 |
| Ra Capital Management, L.P. | Director | 11/26/2024 | AA | Indirect | COM | 389,716 | $14.91 | $5,811,444.99 | 1,092,796 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | 09/11/2024 | DS | Direct | COM | 909 | $11.64 | $10,580.12 | 17,788 |
| Sandison Taylor | Chief Medical Officer | 09/11/2024 | DS | Direct | COM | 924 | $11.64 | $10,752.31 | 23,067 |
| Stein Jeffrey | President & CEO | 06/07/2024 | AP | Indirect | COM | 8,000 | $13.21 | $105,680.00 | 24,580 |
| Sandison Taylor | Chief Medical Officer | 03/15/2024 | AA | Direct | COM | 128,750 | $0.00 | $0.00 | 475,845 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/15/2024 | AA | Direct | COM | 111,250 | $0.00 | $0.00 | 369,931 |
| Shah Preetam | CFO & CBO | 03/15/2024 | AA | Direct | COM | 108,750 | $0.00 | $0.00 | 335,960 |
| Ward Shane | COO & CLO | 03/15/2024 | AA | Direct | COM | 120,000 | $0.00 | $0.00 | 318,770 |
| Shah Preetam | CFO & CBO | 03/11/2024 | DS | Direct | COM | 18,931 | $0.67 | $12,679.98 | 227,210 |
| Ward Shane | COO & CLO | 03/11/2024 | DS | Direct | COM | 20,473 | $0.67 | $13,712.82 | 198,770 |
| Sandison Taylor | Chief Medical Officer | 03/11/2024 | DS | Direct | COM | 20,662 | $0.67 | $13,839.41 | 347,095 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/11/2024 | DS | Direct | COM | 21,029 | $0.67 | $14,085.22 | 258,681 |
| Stein Jeffrey | President & CEO | 03/11/2024 | DF | Direct | COM | 56,692 | $0.69 | $39,117.48 | 1,153,693 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel | |||||||
© 2000 - 2025 Zacks Investment Research